Steven Santiago, MD

Chief Medical Officer
CareResource

Disclosure: Gilead (Advisor or Review Panel member, Speaker's Bureau)Janssen (Speaker's Bureau)

Presentation(s):

• LB-7 - Weight Change in Suppressed People with HIV (PWH) Switched from Either Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) to Tenofovir Alafenamide (TAF)

  Saturday, October 24, 2020
  10:50am – 11:00am EDT